Work

Biomarker Appendix from BATON-CRC: A Phase II Randomized Trial Comparing Tivozanib Plus mFOLFOX6 with Bevacizumab Plus mFOLFOX6 in Stage IV Metastatic Colorectal Cancer

Year: 2023
Type: other
Abstract: Biomarker Appendix
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: gold
OpenAlex ID: W4361927513
Cites:
Cited by:
Related to: 10